Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression
Walison da Silva,
No information about this author
Pedro Augusto Carvalho Costa,
No information about this author
Sérgio Ricardo Scalzo Júnior
No information about this author
et al.
International Journal of Nanomedicine,
Journal Year:
2024,
Volume and Issue:
Volume 19, P. 2655 - 2673
Published: March 1, 2024
Introduction:
Immunotherapy
has
revolutionized
cancer
treatment
by
harnessing
the
immune
system
to
enhance
antitumor
responses
while
minimizing
off-target
effects.
Among
promising
cancer-specific
therapies,
tumor
necrosis
factor-related
apoptosis-inducing
ligand
(TRAIL)
attracted
significant
attention.
Methods:
Here,
we
developed
an
ionizable
lipid
nanoparticle
(LNP)
platform
deliver
TRAIL
mRNA
(LNP-TRAIL)
directly
microenvironment
(TME)
induce
cell
death.
Our
LNP-TRAIL
was
formulated
via
microfluidic
mixing
and
induction
of
death
assessed
in
vitro.
Next,
investigated
ability
inhibit
colon
progression
vivo
combination
with
a
TME
normalization
approach
using
Losartan
(Los)
or
angiotensin
1–
7
(Ang(1–
7))
reduce
vascular
compression
deposition
extracellular
matrix
mice.
Results:
results
demonstrated
that
induced
vitro
effectively
inhibited
vivo,
particularly
when
combined
Los
Ang(1–
7).
In
addition,
potent
as
well
enhanced
apoptosis
found
tissue
group
treated
normalization.
Discussion:
Together,
our
data
demonstrate
potential
LNP
death,
especially
Therefore,
these
findings
provide
important
insights
for
development
novel
therapeutic
strategies
immunotherapy
solid
tumors.
Keywords:
immunotherapy,
TRAIL,
mRNA,
nanoparticle,
losartan,
(1–
7)
Language: Английский
Intestinal tissue-resident memory T cells: Characteristics, functions under physiological and pathological conditions and spatial specificity
Ruilan Yan,
No information about this author
Dingjiacheng Jia,
No information about this author
Yinliang Qi
No information about this author
et al.
Journal of Advanced Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Tissue-resident
memory
T
(TRM)
cells
are
a
distinct
subset
of
that
persist
in
non-lymphoid
tissues,
providing
localized
and
rapid
immune
responses
to
infection
malignancy.
Unlike
circulating
cells,
TRM
have
unique
homing
functional
characteristics
shaped
by
the
tissue
microenvironment.
In
gut,
play
pivotal
role
maintaining
mucosal
immunity,
exhibiting
phenotypic
heterogeneity
different
intestinal
compartments
response
aging
pathological
conditions.
This
review
aims
systematically
examine
definition,
spatial
roles
(iTRM)
cells.
It
highlights
their
contributions
physiological
involvement
processes
such
as
inflammatory
bowel
disease
(IBD)
colorectal
cancer
(CRC),
age-related
dynamics.
The
also
explores
emerging
therapeutic
implications
modulating
iTRM
for
health
management.
KEY
SCIENTIFIC
CONCEPTS
OF
REVIEW:
defined
surface
markers
like
CD69
CD103,
transcriptional
regulators
Hobit,
Runx3,
Blimp-1,
well
cytokine
signals
including
TGF-β,
IFN-β,
IL-12.
They
exhibit
across
layers
(epithelium
versus
lamina
propria)
regions
(small
intestine
colon).
IBD,
dual
role,
contributing
both
inflammation
repair,
whereas
CRC,
specific
subsets
(e.g.,
CD8+
CD103+
CD39+)
associated
with
enhanced
antitumor
immunity.
Aging
impacts
functionality,
shifts
CD4+/CD8+
ratio
reduced
production
elderly
individuals.
Insights
into
metabolic,
transcriptional,
environmental
regulation
provide
avenues
targeted
therapies
diseases,
immunotherapy,
interventions
delay
aging.
Language: Английский
Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells
Yongheng Shang,
No information about this author
Yinjun He,
No information about this author
Xiang Zhang
No information about this author
et al.
Immunology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 20, 2025
Tissue-resident
memory
T
cells
(TRMs)
reside
in
peripheral
tissues
and
provide
rapid
immune
defence
against
local
infection
tumours.
Tumour-associated
TRMs
share
common
tissue-resident
features
formation
mechanisms,
representing
some
unique
subsets
of
tumour-infiltrating
lymphocytes
(TILs).
However,
differences
the
tumour
microenvironment(TME)
evolution
stage
result
exhibiting
temporal
spatial
heterogeneity
phenotype
function
not
only
at
different
stages,
before
after
treatment,
but
also
between
tumours
originating
from
tissues,
primary
metastatic
cancer,
adjacent
normal
tissue.
The
infiltration
is
often
associated
with
immunotherapy
response
favourable
prognosis;
however,
due
to
definitions,
it
has
been
shown
that
subtypes
can
have
a
negative
impact.
Therefore,
crucial
precisely
characterise
TRM
subpopulations
influence
therapeutic
efficacy
clinical
prognosis
various
solid
Here,
we
review
spatiotemporal
tumour-associated
TRMs,
as
well
their
impact
on
outcomes.
We
explore
relationship
checkpoint
blockade
(ICB)
TIL
therapy,
providing
insights
into
potential
new
targets
strategies
for
immunotherapy.
Language: Английский
Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy
Eun Suk Seo,
No information about this author
Sung‐Kyu Lee,
No information about this author
Young Min Son
No information about this author
et al.
Cancer Immunology Immunotherapy,
Journal Year:
2025,
Volume and Issue:
74(6)
Published: April 26, 2025
Tissue-resident
memory
T
(TRM)
cells
are
well
reported
as
a
strong
protective
first
line
of
defense
against
foreign
antigens
in
non-lymphoid
tissues.
Moreover,
TRM
have
demonstrated
critical
roles
antitumor
immunity,
contributing
to
enhanced
survival
and
tumor
growth
inhibition
across
various
cancer
types.
However,
surprisingly,
recent
studies
suggest
that
can
exhibit
paradoxical
effects,
potentially
promoting
progression
under
certain
conditions
leading
adverse
outcomes
during
immune
responses.
Understanding
the
complexities
cell
functions
will
enable
us
harness
their
potential
advancing
immunotherapy
more
effectively.
Therefore,
this
review
comprehensively
investigates
dual
different
contexts,
highlighting
combating
cancers
unfavorable
exacerbate
development.
Additionally,
we
explore
implications
behaviors
for
future
treatment
strategies,
emphasizing
need
further
research
optimize
therapeutic
exploitation
while
mitigating
deleterious
effects.
Language: Английский
Does side matter? Deciphering mechanisms that underpin side-dependent pathogenesis and therapy response in colorectal cancer
Harrison J Boka,
No information about this author
Rebekah Engel,
No information about this author
Christine Georges
No information about this author
et al.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: May 2, 2025
Language: Английский
CD39 transforming cancer therapy by modulating tumor microenvironment
Suling Xu,
No information about this author
Yuhan Ma,
No information about this author
Xinyu Jiang
No information about this author
et al.
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
597, P. 217072 - 217072
Published: June 15, 2024
CD39
is
a
pivotal
enzyme
in
cancer,
regulating
immune
response
and
tumor
progression
via
extracellular
ATP
adenosine
the
microenvironment
(TME).
Beyond
its
established
immunoregulatory
function,
influences
cancer
cell
angiogenesis
metabolism,
opening
new
frontiers
for
therapeutic
interventions.
Current
research
faces
gaps
understanding
CD39's
full
impact
across
types,
with
ongoing
debates
about
potential
beyond
modulating
evasion.
This
review
distills
multifaceted
roles,
examining
dual
actions
implications
prognosis
treatment.
We
analyze
latest
strategies,
highlighting
need
an
integrated
approach
that
combines
molecular
insights
TME
dynamics
to
innovate
care.
synthesis
underscores
integral
role,
charting
course
precision
oncology
seeks
unravel
controversies
harness
promise
improved
outcomes.
Language: Английский
Single-cell transcriptomics and Mendelian randomization reveal LUCAT1’s role in right-sided colorectal cancer risk
Zhihao Shang,
No information about this author
Xi Songyang,
No information about this author
Yueyang Lai
No information about this author
et al.
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: April 22, 2024
Background:
Colorectal
cancer
(CRC)
is
a
malignancy
with
high
incidence
and
mortality
rates
globally,
categorized
into
left-sided
right-sided
CRC,
each
exhibiting
significant
differences
in
molecular
characteristics,
clinical
manifestations,
prognosis.
Methods:
This
study
employed
single-cell
transcriptomic
data
various
bioinformatics
approaches,
such
as
two-sample
Mendelian
randomization,
reverse
colocalization
analysis,
directed
filtering,
pseudotime
intercellular
communication
analysis.
It
analyzed
cellular-level
disparities
between
identifying
distinct
subpopulations
characteristic
variations.
For
these
cells,
randomization
was
utilized
to
explore
gene-to-one-sided
CRC
causality.
Results:
LUCAT1
enriched
high-abundance
monocyte
demonstrated
potential
risk
factor
status
through
The
specific
single-nucleotide
polymorphism
(SNP)
rs10774624
associated
an
increased
of
CRC.
Moreover,
metabolic
pathway
analysis
revealed
that
+
monocytes
exhibit
lower
activity
the
tumor
microenvironment
heightened
functions
like
glycosaminoglycan
degradation.
Its
biological
are
related
positive
regulation
interleukin-6
production
NF-kappa
B
signaling,
among
others.
Conclusion:
confirmed
causal
relationship
These
findings
provide
novel
insights
pathogenesis
may
aid
developing
early
detection
treatment
strategies
for
Language: Английский
Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications
Hiromichi Sato,
No information about this author
Sikun Meng,
No information about this author
Tomoaki Hara
No information about this author
et al.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 1342 - 1342
Published: June 17, 2024
Gastrointestinal
cancers,
which
include
a
variety
of
esophageal
and
colorectal
malignancies,
present
global
health
challenge
require
effective
treatment
strategies.
In
the
evolving
field
cancer
immunotherapy,
tissue-resident
memory
T
cells
(Trm
cells)
have
emerged
as
important
players
in
immune
response
within
nonlymphoid
tissues.
this
review,
we
summarize
characteristics
functions
Trm
discuss
their
profound
implications
for
patient
outcomes
gastrointestinal
cancers.
Positioned
strategically
peripheral
tissues,
beyond
surveillance,
affecting
tumor
progression,
prognosis,
to
immunotherapy.
Studies
indicate
that
are
prognostic
markers
correlate
positively
with
enhanced
survival.
Their
presence
microenvironment
has
sparked
interest
therapeutic
potential,
particularly
respect
checkpoint
inhibitors,
may
improve
treatment.
Understanding
how
work
will
not
only
help
prevent
spread
through
but
also
contribute
disease
prevention
at
early
stages
well
vaccine
development.
The
role
goes
just
cancer,
they
potential
applications
infectious
autoimmune
diseases.
This
review
provides
thorough
analysis
lead
personalized
therapies.
Language: Английский
Inhomogeneously distributed ferroptosis with a high peak-to-valley ratio may improve the antitumor immune response
Mau-Shin Chi,
No information about this author
Der‐Chi Tien,
No information about this author
Kwan‐Hwa Chi
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: Aug. 28, 2023
Combined
radiotherapy
(RT)
and
mild
hyperthermia
have
been
used
clinically
for
decades
to
increase
local
control.
Both
modalities
tend
achieve
a
homogeneous
dose
distribution
within
treatment
targets
induce
immunogenic
cell
death.
However,
marked,
long-lasting
abscopal
effects
not
usually
observed.
We
proposed
hypothesis
emphasize
the
importance
of
peak-to-valley
ratio
inside
tumor
ferrroptosis
in
peak
area
while
avoid
nonimmunogenic
ferroptosis
valley
area.
Although
inhomogeneous
distributed
energy
absorption
has
noted
many
anticancer
medical
fields,
idea
sedulously
created
inhomogeneity
related
antitumor
immunity
discussed.
To
scale
up
ratio,
we
possible
implications
by
combination
nanoparticles
(NP)
with
conventional
RT
or
hyperthermia,
use
high
modulation
depth
extremely
low
frequency
resolution
spatially
fractionated
(SFRT)
enhance
immune
reactions.
Language: Английский
PEPSI: Polarity measurements from spatial proteomics imaging suggest immune cell engagement
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 17, 2023
Subcellular
protein
localization
is
important
for
understanding
functional
states
of
cells,
but
measuring
and
quantifying
this
information
can
be
difficult
typically
requires
high-resolution
microscopy.
In
work,
we
develop
a
metric
to
define
surface
polarity
from
immunofluorescence
(IF)
imaging
data
use
it
identify
distinct
immune
cell
within
tumor
microenvironments.
We
apply
characterize
over
two
million
cells
across
600
patient
samples
find
that
identified
as
having
polar
expression
exhibit
characteristics
relating
tumor-immune
engagement.
Additionally,
show
incorporating
these
polarity-defined
subtypes
improves
the
performance
deep
learning
models
trained
predict
survival
outcomes.
This
method
provides
first
look
at
using
subcellular
patterns
phenotype
with
applications
precision
medicine.
Language: Английский